Meyer Pharmaceuticals Report issue

For profit Phase 2
Founded: Irvine CA United States (1996)
Status: Defunct (2008)

Organization Overview

First Clinical Trial
1998
NCT00003780
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

gemcitabine (gemzar) (1 trial)

tumour infiltrating lymphocytes (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pancreatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2